UroCure, founded with the mission to advance women's health, focuses on designing and commercializing FDA-approved slings for female incontinence. The company re-commercializes intellectual property originally developed by American Medical Systems (AMS), ensuring high-quality, patient-centered solutions for stress urinary incontinence (SUI). UroCure offers a range of midurethral sling systems tailored to various surgical techniques, including bottom-up, top-down, and outside-in approaches.
Notable figures associated with UroCure include experienced healthcare professionals and investors committed to improving women's health outcomes. The company has achieved significant milestones by successfully re-submitting products for FDA clearance through the established 510(k) pathway. UroCure's innovative approach and dedication to leveraging proven technologies have made a substantial impact on the market, providing effective and reliable solutions for women suffering from SUI.